(Q40524595)

21 September 2017

1 reference

title

Platelet activating factor antagonists (English)

1 reference

21 September 2017

Summers JB

1

1 reference

PubMed ID

7748804

21 September 2017

Albert DH

series ordinal

2

1 reference

21 September 2017

1 January 1995

1 reference

21 September 2017

Advances in Pharmacology

1 reference

21 September 2017

32

1 reference

21 September 2017

67-168

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

21 September 2017

1 reference

7 January 2021

Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Safety, tolerability, and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Human and rabbit platelets form platelet-activating factor in response to calcium ionophore

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Design of potent linear PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Endotoxin-induced myocardial depression in rats: effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Structural analysis of purified platelet-activating factor by lipases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Infarct reduction by the platelet activating factor antagonist apafant in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Differential plasma duration of antiplatelet-activating factor and antihistamine activities of oral Sch 37370 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Acute microvascular effects of PAF-acether, as studied by intravital microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition of Platelet-Activating Factor Fails to Limit Ischemia and Reperfusion-Induced Myocardial Damage

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Gram-negative sepsis: a dilemma of modern medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

How gram-positive organisms cause sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The Ginkgolides: Potent platelet-activating factor antagonists isolated from Ginkgo biloba L.. Chemistry, pharmacology and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Is there a case for PAF antagonists in the treatment of ischemic states?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Recent progress in ginkgolide research

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Myocardial reperfusion: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor in porcine Pseudomonas acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The role of platelet-activating factor in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Hypoxia causes ischemic bowel necrosis in rats: the role of platelet-activating factor (PAF-acether)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

(Pyridylcyanomethyl)piperazines as orally active PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: Present status

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor: receptors and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Desensitization of human platelets by platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF antagonists. Their potential therapeutic role in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Long-term lung preservation with the PAF antagonist BN 52021.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Total synthesis of (.+-.)-ginkgolide B

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor production during hemodialysis: effect of BN 52021

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Interplay of complement and cytokines in the pathogenesis of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

[3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Presence of specific binding sites for platelet-activating factor (PAF) in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Characterization of platelet-activating factor receptors in porcine platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Nitric oxide modulates vascular permeability in the rat coronary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Neutrophil aggregating properties of PAF-acether and leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Histological evidence of initiating factors in acute necrotising pancreatitis in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Prolonged survival of renal transplants in nonimmunized and hyperimmunized rats receiving a platelet-activating factor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor and progressive brain damage following focal brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Mechanism and regulation of neutrophil priming by platelet-activating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagoni

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF receptor structure: A hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor effects on bovine pulmonary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Propenyl carboxamide derivatives as antagonists of platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Binding of [3H]SR 27417, a novel platelet-activating factor (PAF) receptor antagonist, to rabbit and human platelets and polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor type activity in plasma from patients with septicemia and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of PAF-acether inhalation on nonspecific bronchial reactivity and adrenergic response in normal and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Terfenadine effect on the bronchoconstriction, dermal response, and leukopenia induced by platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of Platelet-activating Factor in Mediating Tumor Necrosis Factor Alpha-induced Pulmonary Vasoconstriction and Plasma-Lymph Protein Transport

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Reappraisal of the role of endotoxin in the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Specific binding sites for platelet activating factor in human lung tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Species difference in the specific receptors of platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Specific receptor sites for platelet activating factor on rat liver plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a selective PAF antagonist SM-10661 ((±)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Characteristics of the binding of platelet-activating factor to platelets of different animal species.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Synthesis of PAF-acether and blood volume changes in gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of PAF in ischemia-reperfusion injury in the rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Specific binding of 1--alkyl-2-acetyl--glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Release of platelet-activating factor in acute experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Overproduction of nitric oxide in cytokine-mediated and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Time course of various inflammatory mediators during recurrent endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor antagonists do not attenuate delayed posttraumatic cerebral edema in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of platelet activating factor in pathogenesis of acute pancreatitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by Triazolobenzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Production and effects of platelet-activating factor in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of inhaled platelet-activating factor on bronchial inflammation in atopic non-asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Does inhaled PAF cause airway hyperresponsiveness in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF receptor and “cache-oreilles” effect. Simple PAF antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Bile-induced acute experimental pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacological profile of 48740 R.P., a PAF-acether antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pathogenesis of disseminated intravascular coagulation in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor in stroke and brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Occupancy of platelet receptors for platelet-activating factor in patients with septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The role of the neutrophil and free radicals in ischemic myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Modulation of leukocyte-mediated myocardial reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor-induced clinical and histopathologic responses in atopic skin and their modification by the platelet activating factor antagonist BN52063.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF antagonism as an approach to the treatment of airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Interactions of prostanoids with the platelet activating factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Structure-Activity Studies on Triazolothienodiazepine Derivatives as Platelet-Activating Factor Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Lack of platelet-activating factor release during reversible myocardial ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs; protective effects of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Reperfusion injury: laboratory artifact or clinical dilemma?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Possible involvement of microtubules in platelet-activating factor-induced increases in microvascular permeability in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Binding and metabolism of platelet-activating factor by human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Studies of platelet activating factor (PAF) antagonists from microbial products. III. Pharmacological studies of FR-900452 in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacologic modulation of experimental postischemic hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The role of platelet activating factor in allergic respiratory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by a platelet-activating factor antagonist (BN 52021)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pathogenetic mechanisms of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: relationship to plasma concentrations in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Dual antagonists of platelet-activating factor and histamine. Identification of structural requirements for dual activity of N-acyl-4-(5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The bronchoconstrictor properties of platelet-activating factor in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacological effecs of oral E6123, a novel PAF antagonist, on biological change induced by PAF inhalation in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Evidence of a role for paf-acether in the pathophysiology of the shock state

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating Factor in Bronchoalveolar Lavage from Patients with Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Diketopiperazines as a new class of platelet-activating factor inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF inhibitory activity of diketopiperazines: Structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor receptor and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet‐activating factor receptor and signal transduction mechanisms 1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Mechanism of platelet activating factor-induced bronchoconstriction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The role of platelet-activating factor in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor does not cause a reproducible increase in bronchial responsiveness in normal man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The effects of a 5-lipoxygenase inhibitor, BW A4C, on the acute response to inhaled PAF in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor involvement in splanchnic artery occlusion shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Immunologic therapy for ARDS, septic shock, and multiple-organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Prospects for an oral Intal

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Molecular cloning and characterization of the platelet-activating factor receptor gene expressed in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

4-Alkyl-1,4-dihydropyridines derivatives as specific PAF-acether antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Stimulation of PAF-synthesis in pulmonary artery endothelial cells by Staphylococcus aureus alpha-toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Demonstration of platelet activating factor receptor in guinea pig kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Role of platelet-activating factor in pulmonary edema after coronary ligation in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Is platelet activating factor (PAF) a mediator of endotoxin shock?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

CV-3988 - a specific antagonist of platelet activating factor (PAF)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Presence of specific platelet-activating factor binding sites in the rat retina

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The metabolic effects of platelet-activating factor antagonism in endotoxemic man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Biphenylcarboxamide derivatives as antagonists of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of thromboxane synthase and cyclooxygenase inhibition on PAF-induced changes in lung function and arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Radioligand binding of antagonists of platelet-activating factor to intact human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of Inhaled PAF in Humans on Circulating and Bronchoalveolar Lavage Fluid Neutrophils: Relationship to Bronchoconstriction and Changes in Airway Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Hetrazepines as antagonists of platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Increased intestinal formation of Paf in endotoxin-induced damage in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Sepsis and septic shock--a review of laboratory models and a proposal

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of a PAF-antagonist (BN 52063) on bronchoconstriction and platelet activation during exercise induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 5. Multiple oxygen substitution of the alkoxy chain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Characterization of a human cDNA that encodes a functional receptor for platelet activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961012-1

7 January 2021

10.1016/S1054-3589(08)61012-1

Identifiers

DOI

0 references

PubMed ID

7748804

1 reference

PubMed ID

7748804